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Abstract: Monozygotic (MZ) twins are typically indistinguishable via forensic DNA profiling. Recently,
we demonstrated that epigenetic differentiation of MZ twins is feasible; however, proportions of
twin differentially methylated CpG sites (tDMSs) identified in reference-type blood DNA were not
replicated in trace-type blood DNA. Here we investigated buccal swabs as typical forensic reference
material, and saliva and cigarette butts as commonly encountered forensic trace materials. As an
analog to a forensic case, we analyzed one MZ twin pair. Epigenome-wide microarray analysis
in reference-type buccal DNA revealed 25 candidate tDMSs with >0.5 twin-to-twin differences.
MethyLight quantitative PCR (qPCR) of 22 selected tDMSs in trace-type DNA revealed in saliva DNA
that six tDMSs (27.3%) had >0.1 twin-to-twin differences, seven (31.8%) had smaller (<0.1) but robustly
detected differences, whereas for nine (40.9%) the differences were in the opposite direction relative
to the microarray data; for cigarette butt DNA, results were 50%, 22.7%, and 27.3%, respectively.
The discrepancies between reference-type and trace-type DNA outcomes can be explained by cell
composition differences, method-to-method variation, and other technical reasons including bisulfite
conversion inefficiency. Our study highlights the importance of the DNA source and that careful
characterization of biological and technical effects is needed before epigenetic MZ twin differentiation
is applicable in forensic casework.
Keywords: forensics; epigenomics; individual identification; monozygotic twins; DNA methylation;
Illumina 450K array; MethyLight; buccal cells; saliva; cigarette butts
1. Introduction
Human genetic variation—in particular, the use of short tandem repeat (STR) markers—allows
for individual identification of known persons, such as donors of biological traces found at crime
scenes [1,2]. The general principle of forensic DNA profiling is the comparison of an STR profile
established from trace DNA of an unknown person collected from the crime scene against STR profiles
established from reference DNA of known persons, such as convicted crime perpetrators whose STR
profiles are stored in the national forensic DNA database. A complete match between an STR profile
from a crime scene trace and that of a known person indicates that the matching person is indeed the
trace donor. However, except for extremely rare cases [3], such conventional forensic DNA profiling
fails to discriminate monozygotic (MZ) twins from within a given pair, which can be forensically
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relevant in both criminal and paternity casework. This challenge is due to the fact that MZ twins from
the same pair derive from the same zygote, hence sharing an ‘identical’ genome sequence and the
same forensic STR profile. In forensic cases where there is no other evidence available, courts will
have no choice but to continue ruling towards setting prime suspects free [4,5], because no individual
conclusion can be derived from DNA evidence. Therefore, a suitable molecular approach needs to be
developed to differentiate MZ twins from crime scene stains to be able to solve such criminal cases.
Based on theoretical considerations [6] and recently demonstrated using ultra-deep,
whole-genome DNA sequencing (WGS) [7], it was previously predicted that individual-specific,
but extremely rare, somatic mutations in form of single-nucleotide polymorphisms (SNPs) can possibly
occur at some point during early development in one, but not the other, MZ twin individual; these can
be arguably used for MZ twin differentiation. The main drawbacks of this genetic approach to
discriminating MZ twins from each other includes the rarity (if they exist at all) of these SNPs,
making it very difficult to locate them across the genome; it is only possible when ultra-deep, highly
expensive WGS is applied. Moreover, because these SNPs need to occur early in cell development to
be MZ twin differentiating, not all cell types used for forensic trace analysis will carry the respective
twin-differentiating SNP allele. The risk of investing in ultra-deep WGS and not succeeding in finding
any informative twin-differentiating SNPs in the tissue type of the crime scene trace makes the
implementation of this genetic approach in routine forensic casework impractical.
In contrast to the stable genome, the epigenome, including various DNA modifications such as
DNA methylation, is dynamic and interchangeable in response to various environmental and stochastic
events [8,9]. Epigenetic studies using phenotypically concordant and discordant MZ twins have been
used in medical research as they account for genetic effects, and are therefore considered ideal for
studying environmental influences on health and disease [10–14]. Observed epigenetic drifts within
MZ twin pairs can be seen not only at specific genomic loci [15,16], but also at a global level [12],
which has unraveled epigenetics’ role in development, ageing, and disease [17–22]. The potential
of DNA methylation profiling for the discrimination between MZ twins in the forensic setting has
already been proposed [23–28]; however, these previous studies mainly included reference-type DNA
such as whole blood or buccal swabs. Investigations were not extended to trace-type DNA such
as from blood or saliva stains, while combining both parts is needed in the forensic setting. Using
small sets of MZ twin pairs and applying genome-wide methylation techniques like the Illumina
Infinium Human Methylation BeadChip microarrays or methylated DNA immunoprecipitation, forensic
researchers identified a number of differentially methylated genomic regions in blood [23–25] using
diverse methylation difference thresholds. Most of these were located within CpG islands (<500 bp long,
>55% GC content, [29]), indicating their potential involvement in gene regulation. Together with blood,
twin-to-twin methylation differences have also been investigated in buccal cells, but mainly using more
targeted approaches and studying satellite DNA and interspersed repeats. Global LINE-1 methylation
analyzed via pyrosequencing was found to be differentially methylated in a small proportion of the
studied MZ twin pairs, and significantly correlated with age [26]. In another study, Alu methylation
analyzed via high-resolution melting curve analysis showed potential for MZ twin differentiation, but the
low resolution and the required large sample volume bring its forensic applicability into question [27].
MZ twin studies examining the extent of epigenetic differences, the degree that these are shared
between difference pairs, and the feasibility of the epigenetic-based approach in forensic casework are
limited thus far. In a recent study, we investigated epigenetic differentiation of MZ twins in a forensic
setting in blood by applying a twin pair-specific approach to 10 MZ twin pairs [30]. Using genome-wide
microarray-based screening in high-quality and -quantity reference-type blood DNA, we discovered
19–111 twin differentially methylated sites (tDMSs) per MZ twin pair (methylation difference threshold
of >0.3). However, only two of the top three tDMSs per pair were successfully validated in the
same blood DNA samples by means of methylation-specific SYBR Green-based quantitative (q)PCR.
Moreover, two-thirds of the validated tDMSs showed substantial differences in low-quality and
-quantity trace-type DNA from small bloodstains. These findings indicate that there are various
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sources of technical and biological variation, one of them being the DNA source as DNA methylation
can be tissue-specific [31–34] and affected by different cell type compositions [35–37].
In the present study, we extended our investigation on the epigenetic differentiation of MZ twins
to those biological materials most often confronted within criminal casework, namely buccal swabs,
cigarette butts, and saliva. Following the forensic setting, we used buccal swab DNA as reference-type
material to resemble high-quality and -quantity reference DNA obtained from buccal swabs collected
as reference material in forensic casework. Also, saliva and ‘used’ cigarette butts were collected as
trace-type material to resemble low-quality and -quantity trace DNA obtained from this evidence
type at crime scenes. Keeping with the forensic setting, we used one MZ twin pair, because in a given
forensic case only one MZ pair will be investigated. Moreover, because DNA methylation differences
between the genetically identical MZ twins are assumed to be pair-specific due to individualized
environmental differences [38], investigating more pairs would not increase the knowledge reliability
per tDMSs used, as every MZ pair will have different tDMSs [30]. As an analog to a forensic case, we
performed the discovery of candidate tDMSs in reference-type buccal cell DNA via genome-wide DNA
methylation microarray analysis; this was followed by candidate tDMS analysis in trace-type DNA
from saliva and cigarette butts using the TaqMan-based quantitative PCR (qPCR) method (MethyLight),
which, in contrast to microarrays, is sensitive enough for low-quality and -quantity trace DNA analysis.
To the best of our knowledge, this is the first study addressing epigenetic MZ twin differentiation
in the forensic setting using epithelial materials and applying a combination of genome-wide and
targeted DNA methylation analysis.
2. Materials and Methods
2.1. Sample Collection
This study was approved by the St Thomas’ Hospital Local Ethics Committee (07/H0802/84,
10.09.2010), and participants provided signed informed consent prior to sample collection. The pair
of twins used in this study are European female MZ twins, aged 52.5 years. The monozygosity of
the twins was confirmed by genotyping 15 highly polymorphic STR loci using the AmpFLSTR™
Identifiler™ PCR Amplification kit (Thermo Fisher Scientific, Waltham, MA, USA). Both twins donated
buccal swabs, saliva samples, and ‘used’ cigarette butts. Saliva was collected in Oragene® RNA
(RE-100) tubes (DNA Genotek, Kanata, ON, Canada) following standard manufacturer procedures,
with the conditions of absence of eating, drinking, or smoking for at least 30 min prior to collection.
Four cigarette butts were also collected by using simulated smoking conditions. The participants were
asked to bring the unlit cigarette filter to the lips and inhale through the filter at least 10 times with
an interval of 1 min between each inhale. All samples were stored at −80 ◦C until DNA extraction
and analysis.
2.2. DNA Sample Preparation
Total DNA from buccal swabs, representing reference-type samples, was extracted using the
DNeasy Blood & Tissue kit (QIAGEN, Hilden, Germany) according to the manufacturer’s instructions.
Saliva DNA was extracted using the QIAamp® DNA Investigator kit (QIAGEN) by following the
protocol: Isolation of Total DNA from Small Volumes of Blood or Saliva. As suggested by Oragene®
RNA (DNAGenotek), 100 µL of saliva was first incubated for 1 h at 50 ◦C prior to extraction.
The following modifications were applied in order to further maximize and concentrate the DNA
yield; 40 µL of ATL buffer was also added to each saliva sample, solutions were incubated at 56 ◦C
for 2 h, and DNA was eluted in 40 µL of elution buffer. DNA from the cigarette butts was extracted
using an adjusted salting-out extraction method [39]. Briefly, cigarette butt papers were placed
in lysis buffer and incubated at room temperature for one day. Subsequently, proteinase K and
10% sodium dodecyl sulfate (SDS) were added and solutions were incubated at 55 ◦C for 3 h and at
37 ◦C overnight. Next, NaCl was added and the solution was centrifuged to collect the supernatant.
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Later on, isopropanol was added and after centrifuging the supernatant was removed. This step was
repeated with ethanol. The remaining pellet containing the DNA was eluted in 40 µL of RNase-free
water. DNA samples were quantified using the Quantifiler® Human DNA Quantification kit (Thermo
Fisher Scientific), according to the manufacturer’s protocol.
In addition, eight DNA standards of known methylation levels (0–100%) were prepared from
low- and high-methylated genomic DNA (EpigenDx, Hopkinton, MA, USA) and were co-analyzed
together with the samples. For genome-wide analysis, 750 ng of extracted buccal cell DNA was
bisulfite-converted using the EZ DNA Methylation™ Kit (ZymoResearch, Irvine, CA, USA). For qPCR
analysis, 200 ng of extracted saliva or standard DNA and 75 ng of extracted cigarette butt DNA (due to
lower yield from these samples) were bisulfite-converted with a MethylEdge™ Bisulfite Conversion
system kit (Promega, Madison, WI, USA). Bisulfite-converted DNA samples were diluted down to
1 ng/µL prior to qPCR. A bisulfite-converted, fully methylated DNA standard (EpiTect Control DNA,
QIAGEN) was used as positive control to prepare a dilution series of eight standards with known
concentrations (10–0.0781 ng/µL) and was included in each MethyLight assay.
2.3. Genome-Wide DNA Methylation Profiling and Data Processing
Genome-wide DNA methylation profiles used in this study were generated using the Illumina
Infinium Human Methylation 450K BeadChip array (Illumina, San Diego, CA, USA). Intensity images
were captured using GenomeStudio (2010.3) Methylation module (1.8.5) software (Illumina).
The Illumina 450K BeadChip assay allows for quantification of DNA methylation levels at 485,512 CpG
dinucleotides. For each CpG site, a β value was estimated, ranging from zero, representing
completely nonmethylated, to one, representing completely methylated sites. Here, we considered
a total of 345,858 probes for our downstream analyses, as a result of stringent quality control
procedures, and following the removal of X/Y chromosome probes and CpG sites with identical
methylation profiles (0% difference between the twins). To account for technical biases and
nonbiological variation including batch effects, we performed two types of normalization of the
450K array results—subset-quantile (SWAN) [40] and functional normalization (FUNNORM) [41],
both implemented in Bioconductor package Minfi [42]. In the normalized datasets, to examine the
overall similarity of DNA methylation profiles of MZ twins, we computed the correlation across all CpG
sites using Pearson’s correlation (r). Based on the average normalized beta value, CpGs were classified
as hypomethylated (average β ≤ 0.3, deficiency of methylated alleles), intermediately methylated
(average 0.3 < β < 0.7), and hypermethylated (average β ≥ 0.7, overabundance of methylated alleles).
2.4. Candidate Twin Differentially Methylated CpG Site Selection
Genome-wide data normalized by both the FUNNORM and SWAN methods were used to select
potential tDMSs by following some quality control steps. Firstly, DNA methylation probes that
mapped to multiple locations of the reference sequence (with exact sequence match and within two
base pair mismatches, N = 30,970) and probes that contain a nonrare polymorphism in the CG site,
minor allele frequency (MAF) >0.1 in the European population from 1000 genomes (N = 24,875),
were removed. Secondly, markers demonstrating DNA methylation values lower than 0.15 and
higher than 0.85 (extreme methylation states) were excluded as they were considered as high risks for
technical errors (38.9% and 40.9% in FUNNORM and SWAN datasets, respectively), as also seen in
our previous investigation when analyzing candidate tDMSs in whole blood [30]. Following quality
control, the absolute methylation difference for each CpG site within the MZ twin pair was calculated
in both datasets. Both FUNNORM and SWAN twin-to-twin methylation differences were categorized
by applying different thresholds (≥0.30, ≥0.40, and ≥0.50). For qPCR method development, we only
considered tDMSs identified by both normalization strategies.
Genes 2018, 9, 252 5 of 25
2.5. MethyLight
MethyLight is a TaqMan-based, highly sensitive qPCR technique that relies on the hybridization
and cleavage of probes specifically designed to target the CpG of interest [43] (Figure A1). For targeted
analysis, the top 25 candidate tDMSs were used for MethyLight assay design. The chromosomal
location of the selected tDMSs and the surrounding DNA region were confirmed and extracted
using the online Ensemble genome browser (human GRCh37/hg19 genome) [44]. The expected
bisulfite-converted DNA sequences were subsequently used to design bisulfite-specific primers for
each CpG assay using the BiSearch software [45]. Some of the applied parameters include the primer
length (17–26 bp), the PCR product length (<300 bp), and the similarity of primer melting temperature
(<5 ◦C). The selection was based on the assay-specific scores provided by the software and the presence
of potential nonspecific PCR product(s). The AutoDimer software [46] was used to assess the formation
of primer dimers and hair-pins. Each methylation-specific probe was designed to bind to the sequence
that includes the CpG of interest and labelled with the 6-Carboxyfluorescein (6-FAM) fluorophore
at the 5′ end. The reference repetitive element Alu was used as a methylation-independent control
reaction for normalizing the amount of DNA input using previously reported primers [27,31,32].
The Alu probe was labelled with Cy5 fluorophore to differ from the CpGs of interest. Due to technical
difficulties (CG-rich DNA sequence), no assay could be designed for one tDMS (cg12047941).
The qPCR assays were developed based on the EpiTect MethyLight PCR + ROX™ Vial Kit
(QIAGEN) and the Bio-Rad CFX96 Touch™ Real-Time PCR Detection System (Bio-Rad, Hercules, CA,
USA). Each assay was optimized in terms of various parameters including primer/probe annealing
temperature and concentration. Two assays (cg11777917 and cg17080283) failed the optimization step
due to the generation of nonspecific PCR products, resulting in the successful final development of
23 (22 tDMSs and Alu) MethyLight assays (Table A1). Each optimized assay was performed in 10 µL
reactions in triplicate, including 5 µL of the 2X EpiTect MethyLight reaction buffer, 1 µL of primer
mix (forward and reverse), 1 µL of hybridization methylation-specific probe, 1 µL of 25 µM MgCl2,
1 µL of bisulfite converted DNA (corresponding to ~1 ng), and 1 µL of RNase-free water. The final
concentration of primer and probes depends on the assay and ranges over 0.4–2 µM and 0.2–1 µM,
respectively; this can be found in Table A1. The thermocycling program was set as follows: an initial
polymerase activation step at 95 ◦C for 5 min, followed by 40 cycles of denaturation step at 95 ◦C for
15 s and annealing/extension step at 55–60 ◦C for 60 s, depending on the assay (Table A1).
2.6. Quantitative PCR Data Analysis
The efficiency (e) of each qPCR assay was provided by the standard curve slope of the serially
diluted DNA standards (positive controls) according to the equation [47]
e = 10− 1/slope − 1. (1)
For each reaction, we obtained the quantification cycle (Cq) value, which describes the cycle
required to reach the threshold—set in this case at 100 relative fluorescent units (RFU)—in which
fluorescence can be detected. The DNA copy number (cn) was calculated using e and the average Cq,
in the equation
cn = e−Cq. (2)
Finally, the methylation ratio was calculated using the formula [43,47–49]
DNA methylation ratio =
( cnCpG
cnAlu
)
sample( cnCpG
cnAlu
)
f ully methylated standard
. (3)
For each sample and standard, the mean and standard deviation of DNA methylation were
calculated using the triplicate reactions. Sample reactions with methylation levels falling outside of the
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range mean ± standard deviation were considered as outliers (technical artifacts due to suboptimal
amplification) and, therefore, excluded from analysis. Finally, the detected methylation values of the
DNA standards of known methylation levels (0–100%) were used to create the best-fitted linearity
curve per assay. The resulting equation based on a minimum of five DNA methylation standards was
used to normalize the observed average methylation value of each sample (Table A2).
3. Results
3.1. Distribution and Twin–Twin Correlation of Genome-Wide Methylation Array Data in Reference-Type
Buccal DNA
While the Illumina 450K microarray generally has high reproducibility [50], β values underwent
two different normalization approaches to assess technical bias. Considering all CpG sites in buccal
cell DNA following quality control and normalization, and by excluding the completely identical ones
with 0% twin-to-twin methylation differences, the methylation level demonstrated the typical bimodal
distribution for each of the two MZ twin individuals (Figure 1a). Based on our β-value cut-offs taking
into account both individuals and normalization strategies, on average, 24.97% of CpGs were classified
as hypomethylated (β ≤ 0.3), 26.95% were intermediately methylated (0.3 < β < 0.7), and 48.08% were
classified as hypermethylated (β ≥ 0.7). We then explored the correlation between the co-twins
considering the CpG sites in the final genome-wide microarray dataset. The observed twin-to-twin
correlations (r) were 0.953 and 0.962 using functional and subset-quantile normalization, respectively
(Figure 1b). The high correlation we observed here in buccal cells from this one MZ pair is slightly lower
compared to previous genome-wide estimates from MZ twins in buccal cells (r = 0.981–0.994, 10 MZ
twin pairs [13]), and also lower compared to those from their whole blood (0.992, [30]). The advanced
age of the MZ pair used here at time of sampling (52.5 years) and tissue-specific methylation differences
could partly explain these results, as shown previously [11]. The observed high correlation is mainly
driven by the vast majority of invariable CpG sites that are either hypo- or hypermethylated in both
twins. The small DNA methylation differences between the MZ twins may be attributed in part to
stochastic processes and/or MZ discordance for environmental exposures, phenotypes, and diseases,
leading to distinct epigenetic changes at the single CpG level [11].
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3.2. Identification of Candidate Twin Differentially Methylated CpG Sites from Microarray Screening in
Reference-Type Buccal DNA
To identify candidate tDMSs in reference-type DNA obtained from buccal swabs, we applied
various quality control steps as described in Section 2.4. The number of potential tDMSs resulting from
both normalized FUNNORM and SWAN datasets and at different twin-to-twin methylation difference
thresholds (≥0.3, ≥0.4, and ≥0.5) is shown in Table 1.
Table 1. Potential twin differentially methylated CpG sites (tDMSs) derived from genome-wide microarray
screening following two normalization strategies (functional—FUNNORM and subset-quantile—SWAN)
and three methylation difference thresholds.
Normalization Method Number of Potential tDMSs (% of Total Analyzed CpGs)
Threshold > 0.495 >0.395 >0.295
FUNNORM 239 (0.07%) 998 (0.29%) 4.208 (1.22%)
SWAN 66 (0.02%) 411 (0.18%) 2.068 (0.60%)
Shared by both methods 61 (0.02%) 363 (0.11%) 1.751 (0.51%)
As may be expected, the number of candidate tDMSs varied between the two normalization methods,
as each accounts for different types of between-sample (FUNNORM) and within-array (SWAN) technical
biases [51]. Taking into account CpG sites reaching the threshold values in both datasets, we identified
129 candidate tDMSs showing ≥0.4 twin-to-twin methylation differences (11 of which showing ≥0.5).
These findings suggest that tDMSs in buccal cells are limited (0.02% considering all 450K CpGs), yet
existing. The majority of candidate tDMSs (83%), found equally on the forward and reverse DNA strands
across all 22 chromosomes, were located on or near genes (Figure 2b,c), with more than half located
in the gene body (60.1%) and the rest in other function regions like the 5′-untranslated region (5′-UTR)
(8.4%) (Figure 2d). Moreover, considering Illumina’s information regarding the 450K probes, 23.3% of
the identified tDMSs at this threshold (≥0.4) are associated with enhancer regions, further highlighting
their potential involvement in regulating gene expression (Figure 2c). Additionally, the 450K probes have
been designed to specifically target CpG islands (CGI) (<500 bp, GC content > 55%, [29]), CGI shores
(up to 2 kb from CGI), CGI shelves (between 2 and 4 kb from CGI), as well as non-CpG island regions
(>4 kb from CGI). Out of the 129 candidate tDMSs, the vast majority (79.1%) are associated with a CGI
(Figure 2e,f). At this cut-off (≥0.4), CGI probes are largely represented, which was also seen in blood [30]
and in other tissues [25,28].
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Figure 2. Representation of identified candidate tDMSs with ≥0.4 twin-to-twin methylation
difference (N = 129) according to (a) Illumina probe type, (b) DNA strand, (c) genomic location,
(d) location/distribution of gene-associated tDMSs (UTR, untranslated region), (e) CpG island,
and (f) location/CpG density of island-associated tDMSs (N, north; S, south).
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3.3. MethyLight Method Development for Top Candidate Twin Differentially Methylated CpG Sites and
Performance Assessment
For qPCR method development, we selected the top 25 candidate tDMSs demonstrating
≥0.5 average twin-to-twin methylation differences in both normalized buccal datasets (Table 2).
The sensitivity and efficiency of each MethyLight assay was tested by analyzing eight DNA standards
derived from a serial dilution of the fully methylated DNA, with concentrations ranging from 10 ng
to 0.078 ng (Table A2). The minimum detected bisulfite-converted, methylated DNA amount for
each assay ranged between 0.078 ng and 1.25 ng. More specifically, 50% of the assays resulted in
successful amplification when using as little as 0.078 ng of methylated DNA input, whereas 5 out of
the 22 assays worked with 0.156 ng of DNA. These results give a strong indication that the selected
method for methylation analysis is very sensitive, and comparable with other forensic DNA-based tests.
Figure A2 includes the standard curves when plotting the average Cq values against the logarithm of
the known DNA concentration, which were linear (R2 = 0.933 − 0.999). Moreover, all assays resulted
in a high efficiency of bisulfite PCR amplification ranging between 70% and 100%. Particularly, 55% of
the assays gave 100% efficiency, whereas 32% resulted in efficiencies higher than 80%.
We also tested the linearity of methylation quantification, where the detected methylation of
commercially available DNA standards with known methylation levels was plotted against the
expected methylation values for every assay (Figure A3). In line with the literature [30,52,53],
the relationship between observed and expected methylation detection differed across the assays from
linear to quadratic polynomial, as a result of different amplification efficiencies and bias. Curves were
skewed either above or below the expected linear curve (blue color, Figure A3), indicating preferential
amplification of the methylated or nonmethylated allele, respectively. Some of these discrepancies for
both the low-methylated (assumed as 0%) and high-methylated (assumed as 100%) DNA standards can
also be explained by variable methylation levels or a small degree of incomplete bisulfite conversion.
To minimize these effects, the equation derived from each linearity curve was used to normalize the
observed methylation values (Table A2). Finally, to test the reproducibility, all qPCR reactions were
performed in triplicate. We calculated the average standard deviation, ranging between 0.010 and
0.044 (Table A2). Compared to other methods like SYBR Green-based qPCR [30], pyrosequencing [54],
and massively parallel sequencing [52], these values are considered low for methylation assays and
are in concordance with other MethyLight studies [55].
Table 2. Top 25 candidate tDMSs selected for MethyLight quantitative (q)PCR assay design.
CpG Assay
FUNNORM SWAN
Average Diff
A B Diff A B Diff
cg01115923 CpG1 0.801 0.207 0.594 0.783 0.193 0.590 0.592
cg23449764 CpG2 0.768 0.173 0.595 0.799 0.266 0.533 0.564
cg14525379 CpG3 0.769 0.194 0.575 0.841 0.295 0.546 0.561
cg26857315 CpG4 0.258 0.850 0.592 0.294 0.807 0.513 0.553
cg18812079 CpG5 0.831 0.310 0.521 0.833 0.252 0.581 0.551
cg07033292 CpG6 0.757 0.157 0.600 0.700 0.212 0.488 0.544
cg17434062 CpG7 0.815 0.247 0.568 0.827 0.314 0.513 0.541
cg11777917 (-) 1 0.841 0.245 0.596 0.749 0.279 0.470 0.533
cg17854471 CpG8 0.782 0.209 0.573 0.737 0.25 0.487 0.530
cg13038544 CpG9 0.193 0.737 0.544 0.202 0.707 0.505 0.525
cg23041250 CpG10 0.760 0.178 0.582 0.699 0.234 0.465 0.534
cg12047941 (-) 1 0.800 0.210 0.590 0.743 0.289 0.454 0.522
cg14737704 CpG11 0.823 0.312 0.511 0.793 0.26 0.533 0.522
cg18562578 CpG12 0.242 0.831 0.589 0.314 0.766 0.452 0.521
cg05415840 CpG13 0.742 0.192 0.550 0.777 0.294 0.483 0.517
Genes 2018, 9, 252 9 of 25
Table 2. Cont.
CpG Assay FUNNORM SWAN Average Diff
A B Diff A B Diff
cg17080283 (-) 1 0.719 0.157 0.562 0.691 0.224 0.467 0.515
cg20482280 CpG14 0.802 0.249 0.553 0.764 0.298 0.466 0.510
cg15904939 CpG15 0.826 0.353 0.473 0.821 0.285 0.536 0.505
cg03353765 CpG16 0.196 0.706 0.51 0.274 0.772 0.498 0.504
cg03571301 CpG17 0.762 0.256 0.506 0.731 0.232 0.499 0.503
cg02961798 CpG18 0.206 0.701 0.495 0.217 0.726 0.509 0.502
cg00134667 CpG19 0.756 0.228 0.528 0.715 0.240 0.475 0.502
cg02886509 CpG20 0.838 0.247 0.591 0.761 0.351 0.410 0.501
cg13460168 CpG21 0.207 0.729 0.522 0.229 0.708 0.479 0.501
cg10399269 CpG22 0.789 0.226 0.572 0.757 0.329 0.428 0.500
1 Excluded from analysis due to unsuccessful method development.
3.4. Saliva DNA Analysis of 22 Top Twin Differentially Methylated CpG Sites Selected from Microarray Data
in Reference-Type Buccal DNA
While all of the selected 22 top tDMSs resulted in twin-to-twin absolute methylation differences of
≥0.4 in buccal DNA, none of them reached this cut-off value in saliva DNA using MethyLight. Looking
at the raw (average) methylation values per individual and per tDMS, these differ significantly with
an average absolute deviation of 0.3 (ranging 0.002–0.756) (Table 3). Only six of the 22 tDMSs (27.3%)
resulted in methylation differences greater than 0.1 (average of 0.144) (Figure 3a), with another seven
of the 22 tDMSs (31.8%) showing smaller but robust differences (<0.1, average of 0.06) in saliva DNA
with MethyLight (Figure A4a,b). For all these 13 tDMSs, the direction of methylation difference was
the same as that seen in buccal DNA with microarrays, meaning that the same twin individual showed
higher methylation in both buccal cell and saliva DNA. The remaining nine of the 22 tDMSs (40.9%)
unexpectedly demonstrated a different direction of twin-to-twin methylation differences (Figure A4c,d).
Interestingly, we observed a pattern concerning twin individuals showing low methylation levels in
buccal cells, with the latter being much increased in saliva (Table 3).
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Figure 3. DNA methylation values of top tDMSs selected from microarray data in reference-type buccal
DNA (blue) and successfully validat d (≥0.1 methyl tion differences wi h the same direction) with
MethyLight qPCR in trace-type DNA from (a) saliva (N = 6), and (b) cigarette butt DNA (N = 11),
(red) for twin individuals A and B. The bars correspond to average detected methylation (triplicate
analysis), while error bars indicate observed standard deviation.
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Table 3. Methylation levels for 22 top tDMSs selected from microarray data in buccal DNA and
analyzed via MethyLight qPCR in saliva and cigarette butt DNA.
Twin Top CpG
Methylation Ratio
Top CpG
Methylation Ratio
Buccal 1 Saliva 2 Cigarettes 2 Buccal 1 Saliva 2 Cigarettes 2
A
1
0.792 0.513 0.268
12
0.278 0.591 0.428
B 0.200 0.378 0.144 0.799 0.303 0.016
A
2
0.784 0.452 0.581
13
0.760 0.557 0.162
B 0.220 0.371 0.135 0.243 0.367 0.020
A
3
0.805 0.193 0.171
14
0.783 0.330 0.341
B 0.245 0.115 0.091 0.274 0.477 0.074
A
4
0.276 0.078 0.092
15
0.824 0.357 0.292
B 0.829 0.107 0.077 0.319 0.605 0.093
A
5
0.832 0.195 0.151
16
0.235 0.513 0.219
B 0.281 0.254 0.185 0.739 0.559 0.119
A
6
0.729 0.727 0.405
17
0.747 0.164 0.086
B 0.185 0.640 0.331 0.244 0.137 0.047
A
7
0.821 0.244 0.234
18
0.212 0.968 0.408
B 0.281 0.216 0.205 0.714 0.413 0.490
A
8
0.760 0.260 0.165
19
0.736 0.477 0.241
B 0.230 0.327 0.057 0.234 0.343 0.099
A
9
0.198 0.368 0.259
20
0.800 0.627 0.259
B 0.722 0.549 0.075 0.299 0.523 0.072
A
10
0.730 0.440 0.311
21
0.218 0.452 0.243
B 0.206 0.320 0.138 0.719 0.249 0.090
A
11
0.808 0.274 0.235
22
0.778 0.429 0.265
B 0.286 0.530 0.023 0.278 0.477 0.162
1 Buccal methylation values were derived from normalized Illumina 450K microarray dataset. 2 Saliva and cigarette
methylation values were derived from MethyLight qPCR.
3.5. Cigarette Butt DNA Analysis of 22 Top tDMSs Selected from Microarray Data in Reference-Type Buccal DNA
As shown in Table 3, the methylation results obtained in cigarette butt DNA are much lower
compared to those of both buccal DNA and saliva DNA. As seen with saliva DNA in the same table,
while all 22 tDMSs resulted in twin-to-twin absolute methylation differences of ≥0.4 in buccal DNA
using the 450K array, none of them reached this cut-off value using MethyLight in cigarette butt
DNA. Looking at the raw (average) methylation values per individual and per tDMS, these differ
significantly with an average absolute deviation of 0.34 (ranging 0.016–0.783) compared to buccal
cell data, and 0.21 (ranging 0.009–0.559) compared to saliva data (Table 3). As shown in Figure 3b,
11 of the 22 tDMSs (50%) resulted in methylation differences greater than 0.1, with 5 of the 22 tDMSs
(22.7%) showing smaller, subtle differences (<0.1), and 6 of the 22 tDMSs (27.3%) showing the opposite
expected methylation profiles and differences (Figure A4c,d).
4. Discussion
The inability to discriminate between identical twins using conventional forensic STR profiling
and the challenges in applying ultra-deep whole-genome sequencing to find rare somatic SNPs [7]
have led forensic researchers to look for alternative ways to differentiate MZ twins via molecular
analysis, with particular attention to DNA methylation profiling [23,25,26]. While DNA methylation
occurs in the 5′ carbon of cytosine in 5′-CpG-3′ positions without affecting the DNA sequence itself,
such epigenetic differences can be detected with both genome-wide screening and targeted methods.
Based on observations derived from genome-wide data, potential candidate markers capable of
discriminating identical twins have been reported in blood [24,25] and buccal cells [12]; however,
studies on testing the forensic feasibility and applicability of this are lacking.
Genes 2018, 9, 252 11 of 25
In this study, we aimed to expand our previous investigation in whole blood [30] by analyzing
other forensically relevant tissues, namely, buccal cells, representing the most typical human biological
material collected as reference material in forensic casework, as well as saliva and cigarette butts
representing materials often found at crime scenes. We identified tDMSs in buccal DNA in one
example MZ pair using the Illumina HumanMethylation450 platform, and analyzed them in saliva
and cigarette butt DNA using the targeted MethyLight approach. This setup was chosen to mimic the
typical forensic casework setting with one specific MZ twin pair in question. The approach includes
the discovery of candidate tDMSs using genome-wide screening technology in reference-type DNA of
sufficiently high quantity and quality (here 750 ng) from buccal swabs, and the subsequent analysis
using trace-sensitive and targeted technology of the most promising identified tDMSs in trace-type
DNA of typically low quality and quantity (here ~1 ng per reaction) from saliva stains and cigarette
butts. Due to the high DNA input requirement of the Illumina HumanMethylation450 platform,
we were unable to type the trace-type DNA with this technology, as this would generate stochastic
loss of probe signals and statistically unreliable data when using suboptimal DNA amounts (<300 ng).
For identifying candidate tDMSs from reference-type buccal cells, the genome-wide DNA
methylation microarray data first underwent various quality control steps aiming to minimize the
chances of technical errors that could be particularly evident when small methylation differences are
expected, as in the case of MZ twins. To this end, we applied different cutoffs of absolute methylation
difference, which resulted in a pool of 129 candidate tDMSs showing differences larger than 0.4.
During our analysis, we avoided not only problematic CpG sites due to nonspecific probes or probes
containing common SNPs, but also CpG sites demonstrating an on/off methylation pattern when
comparing the twins. As shown in Figure 1a, the differences between the two MZ twin individuals
are quite large for CpGs showing very low (<0.15) and very high (>0.85) methylation values; hence,
these were excluded from the top candidate choice as they could contain potential technical errors as a
result of failed or suboptimal performance of one of the two Illumina probes used in the microarray
technology. Justification of this approach is provided by our previous study using blood [29], where
the proportion of candidate tDMSs not successfully validated was considerably higher when including
candidate tDMSs with large twin-to-twin methylation differences in the microarray data, relative to the
validation rate when excluding those, as also applied here. Although we cannot completely explain
this, excluding such CpGs from further analysis avoids one possible error source. Future empirical data
are necessary to further document these potential technical biases related to extreme methylation states.
The second step in our study was to develop a targeted analysis method for the identified
candidate tDMSs markers that provides robust, reproducible, and sensitive DNA methylation detection
suitable for low-quality and low-quantity trace-type DNA. While in our previous investigation of
MZ twin differentiation from blood [29] we successfully applied a SYBR Green-based qPCR method,
in the present study we aimed to improve the accuracy, specificity, and sensitivity of the trace DNA
analysis method by taking advantage of the TaqMan technology. MethyLight has been successfully
used for both singleplex and small-scale methylation analysis before [48,49,55], and was applied for
the purpose of this investigation. An initial method assessment gave very promising results, including
<1 ng minimum bisulfite-converted DNA input (which is considered the optimal DNA input into PCR
in various commercially available STR kits) and <5% standard deviation of the detected methylation.
Each qPCR MethyLight assay has a PCR efficiency ranging from 70% to 100%, which depends on
(i) the DNA sequence itself (CG-rich sequences might be more difficult to amplify); (ii) the specificity
of the genomic sequence; (iii) the length of the PCR product (as bisulfite-converted DNA is often
fragmented); and other technical reasons. Nevertheless, we accounted for the PCR efficiency in our
DNA methylation ratio calculations as explained in Section 2.6. However, due to the singleplex nature
of the method, there are associated limitations in terms of total required DNA input and time required
for method development.
The third step in our study was to verify whether the same methylation differences as seen in
the twins’ buccal cells with microarrays can also be observed in DNA from saliva and ‘used’ cigarette
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butts with trace-sensitive MethyLight qPCR. Generally, we observed much lower methylation levels
in both saliva and cigarette butt DNA with MethyLight, which, as a consequence, resulted in
much lower twin-to-twin differences than observed in buccal DNA with microarrays. We also
observed the opposite twin-to-twin methylation differences for a large proportion of our candidate
tDMSs, potentially introducing false positives in a forensic investigation (identifying the wrong twin
individual). Our inability to verify the buccal-derived methylation data can be explained by various
technical factors in either platform. Despite our efforts to correct them via normalization strategies
(also seen in blood [29]), errors based on method-to-method discrepancies between genome-wide and
targeted methods, difference amplification chemistries and bias, Illumina probe-specific suboptimal
performance, and incomplete bisulfite conversion can lead to alternative results. In the case of cigarette
DNA, together with the factors mentioned above, we consider that lowering the DNA input for
bisulfite conversion used for these samples due to non-availability (75 ng) could have an impact on
our analysis, as it falls outside of the manufacturer’s optimal DNA input range. Nevertheless, from a
forensic perspective, this amount is considered sufficient.
The observed discrepancies, however, can also be explained by biological variation, as introduced
by differential cell-type composition in each of these sample types. While for genetic analysis cell
composition is often not relevant, for epigenetic analysis the tissue of origin is of crucial importance.
It is known that DNA methylation is altered between tissues, not only at a genome-wide level but
also at the single CpG level; therefore, samples with different cell type compositions can demonstrate
different DNA methylation profiles [56,57]. At the single CpG level, DNA methylation is a binary
variable, meaning that at any given CpG site each cell might either be methylated or nonmethylated.
However, the observed DNA methylation ratio as obtained from lab techniques is a result of the
combined methylation profiles of all cells included in the sample. While the vast majority of cells
contained in saliva are of epithelial origin, studies have shown that the cellular content includes
erythrocytes, leukocytes, epithelial cells, and bacteria [13,57]. Similarly, considering the normal use of
cigarettes during smoking, one expects that since cigarette butts come in contact with the mouth, there
is a high probability that obtained DNA originates from saliva (buccal cells and leukocytes) together
with epithelial skin cells from the lips. This study demonstrated that this ascertainment is crucial and
has to be taken into account in future forensic scenarios, especially when matching reference-trace
samples are not available. Given that pure buccal-cell-based forensic material are not likely to be
present at crime scenes, while buccal swabs represent the most commonly used reference material in
forensic casework, such tissue effects have to be carefully documented. Ideally, and to reduce or avoid
epigenetic cell type effects, reference sample collecting strategies should be adaptable towards the
trace sample; for example, collecting and using saliva reference samples in cases where saliva trace
samples are found at the crime scene.
One limitation of our study was that the DNA samples used for reference-type DNA
microarray analysis were no longer available for qPCR testing of the microarray-derived candidate
tDMSs. Unfortunately, in our study, such a technical validation step was impossible due to the
exhaustion of buccal DNA during the microarray analysis (750 ng of extracted DNA due to the
method’s requirements; only one buccal swab was collected). In a forensic setup, this is avoided as
typically several buccal swabs are collected as reference material; this increases the total amount of
reference DNA available and thus allows such technical validation. Initially, we reasoned that the
lack of buccal DNA for qPCR testing could be compensated by using saliva DNA. Based on prior
knowledge at the time of sample collection, saliva DNA methylation was not expected to be so different
from buccal cell DNA methylation. Such sample type DNA methylation differences have only been
highlighted in a more recent study [54] as well as in our study here. In our previous study on whole
blood, we did have DNA used for microarray analysis also available for qPCR validation testing
simply because the previously collected blood sample provided much more DNA than the buccal
swab collected here. There we found that about one-third of the microarray-derived candidate tDMSs
strongly deviated in their qPCR results relative to the microarray data when tested in the very same
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DNA samples, which is explained by method-to-method discrepancies [29]. However, in that study, we
also demonstrated that from those tDMSs that were successfully technically validated, about one-third
strongly deviated in their blood trace DNA results relative to the reference blood DNA data using
the same qPCR method. This previous finding suggests that a proportion of the discrepancies we
observed in the present study between buccal array data and saliva/cigarette butts may be caused by
method issues, but very likely not all of those we observed. Moreover, the discrepancies we found
here between saliva and cigarette butts cannot be explained by method issues as for both forensically
relevant sample types we used the same qPCR approach. In order to make stronger conclusions about
systematic patterns of tissue-specific DNA methylation in our investigated CpGs, more individuals
or twin pairs need to be investigated. However, even in that case, DNA methylation differences
between the MZ twins are expected to be pair-specific due to individualized environmental differences;
therefore, the candidate tDMSs will very likely always be different in every forensic scenario.
From the statistical perspective, it is currently unknown what the minimum number of tDMSs
to be analyzed is to reach a statistically robust identification of twin individuals, but it is likely to be
specific to tissue, twin pair, and forensic case circumstances. If more markers are to be investigated,
other methods allowing for large-scale multiplexing, such as massively parallel sequencing, may
be more suitable. In general, a technology switch from reference-type DNA methylation screening
analysis to trace-type targeted DNA methylation analysis is necessary because the DNA methylation
microarray technology used in high-quality and high-quantity reference-type DNA such as from
buccal cells (or whole blood [29]) is unlikely to work in low-quality and low-quantity trace-type DNA
such as from saliva and cigarette butts (or bloodstains [29]). In the future, given that there is no current
method for accurately quantifying bisulfite-converted DNA and that the experimental design relies
on estimates regarding bisulfite DNA recovery provided by the manufacturer, introducing such a
quantification step after bisulfite conversion will likely improve the accuracy and reproducibility of
the targeted DNA methylation analysis. Moreover, recently there have been a few studies published
proposing a cell type composition scoring in complex tissues as a quality step prior to DNA methylation
analysis [37,58], which can also be adopted in this case to explain DNA methylation differences by cell
type differences as assumed based on the results presented here. For example, this approach could work
by analyzing a small number of certain CpGs with known expected methylation levels, for calculating
the proportion of leukocytes in saliva and correct saliva-based methylation values prior to comparison
with buccal-cell-derived data, as recently demonstrated [37,58]. Lastly, to account for tissue-specific
methylation effects more effectively, a potential strategy could be to use tissue-shared tDMSs, which,
however, remain to be identified in future MZ twin studies involving various forensically relevant
human materials.
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Appendix A
Table A1. MethyLight TaqMan-based qPCR assays for the top 22 tDMSs selected from DNA methylation microarray data in buccal DNA for one MZ twin pair.
Assay CpG Primer Sequence (5′-3′) 1 Primer Length (bp) Ta (◦C) Primer Concentration (µM) PCR Length (bp)
CpG1 cg01115923
F TTTTTTTGTTTATAGTGGGAG 21
60 2/1 86R ACTACTAATCCCAAAACTAAAAA 23
Pm CCRTACCRAAAACTATAACG 2 20
CpG2 cg23449764
F TGTGTGATAGTGAGAAGTATAAA 23
60 2/1 250R AACTTCTAAATCCAATACCA 20
Pm CGAAATAAACATATATAATAACACG 25
CpG3 cg14525379
F GGGTTTATAGATTGTTTTTAGGT 23
60 2/1 249R AAATCTCCTTTACCCTTTTACTT 23
Pm AACAAATATAATAAACTTAAATACCG 26
CpG4 cg26857315
F TTTAGGAGGGAAGTATAGGAA 21
58 1.2/0.6 286R CCCAAAATACTAAAAAACCAAA 22
Pm AAATAAATAAACGCGTCCCG 20
CpG5 cg18812079
F GTATTTAGAGGAGTAGATA 19
58 1.2/0.6 143R TACACCTAAAAAAAATCCCA 20
Pm CTAAAAACCCAATCCTACCG 20
CpG6 cg07033292
F TGTTGATAGTTGTATAGTAG 20
57 0.8/0.4 120R ATAACTAAAAAACCCAACC 19
Pm ACCRTAATTAAAACCAAAACCG 22
CpG7 cg17434062
F TTTTTTGAGGTAGTGTA 17
59 1.2/0.6 167R RCTTCCCCAAAATAAAAATAATC 23
Pm AAATTCCAATATCTAAAATACCCG 24
CpG8 cg17854471
F GTTGTGTTAGTTATTTATTTTTGGG 25
57 0.8/0.4 224R TAAAACCAACCTCATTCTT 19
Pm AAAAATTAACACTATACTATCAACG 25
CpG9 cg13038544
F GGGGGAATTAGGTATTATTTTTA 23
57 1.2/0.6 248R CAAATATAAAAACCCTACTC 20
Pm CGTAACAAAATAAAATCCGCTCG 23
CpG10 cg23041250
F GGTTTTTTTTTTAGGTGT 18
57 0.8/0.4 177R AAAACCTCACCCTAACCTAA 20
Pm ACCTCRCCCTCCACRCG 17
CpG11 cg14737704
F AATTGTTGTGTGTTGGTGGATA 22
55 0.8/0.4 220R ACCAACAATAATAAAAAC 18
Pm AATAAAACTAATAAACTCCACG 22
CpG12 cg18562578
F GAGGATTTTTGTTTGGTTTTT 21
59 0.8/0.4 255R RTAACTCCCTTTCTATATAT 20
Pm CTTCTTTACCAACCACRATACG 22
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Table A1. Cont.
Assay CpG Primer Sequence (5′-3′) 1 Primer Length (bp) Ta (◦C) Primer Concentration (µM) PCR Length (bp)
CpG13 cg05415840
F ATTTTTGAGTTGGGGTTGATT 21
55 0.8/0.4 142R CCCTACAAAAAAAAAAACT 19
Pm ACATCTAAATAACACRAATATATACG 26
CpG14 cg20482280
F TTGGTTGTTTAGGAAGTGTAT 21
56 0.8/0.4 262R AATCTTCCTATAAACAAAAA 20
Pm TCTCCTCTATAACCATATAAAACACG 26
CpG15 cg15904939
F TTTTTAAGGTTGTGAGTTAG 20
56 0.8/0.4 142R ACTAACCCTACTAAAATA 18
Pm AATAACCTAAAATTATCCACCACG 24
CpG16 cg03353765
F TTAGTGGATAGGAAAGTTAA 20
60 1.2/0.6 216R TTTCAAACAACACAAAAACC 20
Pm CGACTACCAAATAAAAACTACTTACG 26
CpG17 cg03571301
F ATTTGTGAATAGTATTATGGGGA 23
60 1.2/0.6 231R CATTTCTCTACCAACAAAAA 20
Pm CCATCCCTATATTTACTAACG 21
CpG18 cg02961798
F GGTTGTTYGGTATTTTTTAGTAGT 24
58 1.2/0.6 191R ATCCTAACTTCTTCCTA 17
Pm CRAAATATACCTAAATATAAAACTCCG 27
CpG19 cg00134667
F AGGAGGGATTTTTTTTAAGGTA 22
56 0.8/0.4 146R AAAAATACCCAACTCTATCT 20
Pm AAATTAATACTTTCCAAATACCG 23
CpG20 cg02886509
F GGAATATTTGTGGGTAAATT 20
58 0.8/0.4 222R RCCACTACTACTTTATTCTCTAA 23
Pm CTCAAAAATCATCACRTCCG 20
CpG21 cg13460168
F TTTTTGATATTTTTGTGGGTGG 22
60 0.8/0.4 187R ATCCCCCRAATTTTATTCTTAAC 23
Pm TCCAAACTTAACAATAAATAACG 23
CpG22 cg10399269
F TTTTTTTATGGTTTGTTGGT 20
57 0.8/0.4 196R AACCTCTATAACCTCAAAAT 20
Pm CRAATAAATAAATATCCCCG 20
Alu
F GGTTAGGTATAGTGGTTTATATTTGTAATTTTAGTA 36
60 2/1 98R ATTAACTAAACTAATCTTAAACTCCTAACCTCA 33
Pm CCTACCTTAACCTCCC 16
1 All tMDS probes were designed to contain the 6-Carboxyfluorescein fluorescent (6-FAM) in the 5′ end and the quencher ZEN-3′ Iowa Black® FQ in the 3′ end of the oligo
(5′-/56-FAM/ZEN/3IABkFQ/-3′). The Alu probe was designed to contain the fluorescent Cy5 in the 5′ end and the quencher TAO-3′ Iowa Black® RQ-Sp in the 3′ end of the
oligo (5′-/5-Cy5/TAO /3IAbkRQSp/-3′). 2 Guanines highlighted in bold bind to complementary methylated cytosines of interest. F: forward; R: reverse; Pm: probe specific for the
methylated allele.
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Table A2. Method performance per MethyLight assay, including minimum DNA input to detect
methylation assessed by the methylated DNA standard serial dilution; average standard deviation
(SD) of methylation detection; and linearity equations for normalizing qPCR methylation data assessed
by DNA standards with known methylation levels.
Assay Min DNA Input (ng) Average SD Equation for Data Normalization
CpG1 0.078 0.036 y = 0.8664x + 0.0182
CpG2 0.625 0.027 y = 1.0412x + 0.0308
CpG3 0.313 0.026 y = 1.056x
CpG4 0.078 0.010 y = 1.0325x + 0.0348
CpG5 0.0625 0.023 y = 0.9772x − 0.0302
CpG6 0.078 0.020 y = −0.5173x2 + 1.5932x − 0.0643
CpG7 0.625 0.020 y = 1.0135x + 0.0613
CpG8 0.078 0.022 y = 0.5787x2 + 0.4094x + 0.0314
CpG8 0.156 0.025 y = 0.9843x + 0.014
CpG10 0.078 0.034 y = 1.0439x − 0.0177
CpG11 0.078 0.025 y = 0.9695x − 0.0221
CpG12 0.156 0.036 y = −0.1247x2 + 1.1728x − 0.1337
CpG13 0.078 0.044 y = 1.1769x − 0.0989
CpG14 0.156 0.024 y = 0.8913x + 0.0585
CpG15 0.156 0.038 y = −1.2737x2 + 2.5978x − 0.3106
CpG16 0.078 0.027 y = 1.2423x − 0.0023
CpG17 0.078 0.026 y = 1.0117x + 0.029
CpG18 0.625 0.018 y = 0.9449x + 0.023
CpG19 0.078 0.036 y = 1.0686x − 0.0282
CpG20 0.078 0.030 y = 0.9236x + 0.0198
CpG21 0.156 0.031 y = 0.4054x2 + 0.6791x − 0.0246
CpG22 0.078 0.033 y = 0.9962x + 0.043
Genes 2018, 9, 252 17 of 25
Genes 2018, 9, x FOR PEER REVIEW  17 of 26 
 
 
Figure A1. Scheme of targeted DNA methylation analysis using MethyLight. Figure A1. Scheme of targeted DNA methylation analysis using MethyLight.
Genes 2018, 9, 252 18 of 25
Genes 2018, 9, x FOR PEER REVIEW  18 of 26 
 
   
   
   
   
   
Figure A2. Cont.
Genes 2018, 9, 252 19 of 25
Genes 2018, 9, x FOR PEER REVIEW  19 of 26 
 
   
   
 
  
Figure A2. Standard curves of methylated DNA copy number for all MethyLight assays 
corresponding to the top 22 tDMSs, as generated by using eight standards from a serial dilution of 
the fully methylated DNA standard (10–0.0781 ng/µL). Each graph plots the average Cq against the 
logarithm of the known DNA concentration, with error bars corresponding to each standard’s 
standard deviation from the three replicates. The best-fitted linear equation is shown in red. 
   
Figure A2. Standard curves of methylated DNA copy number for all MethyLight assays corresponding
to the top 22 tDMSs, as generated by using eight standards from a serial dilution of the fully methylated
DNA standard (10–0.0781 ng/µL). Each graph plots the average Cq against the logarithm of the known
DNA concentration, with error bars corresponding to each standard’s standard deviation from the
three replicates. The best-fitted linear equation is shown in red.
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Figure A3. Linearity curves of methylation quantification for all MethyLight assays corresponding to 
the top 22 tDMSs, as generated by using seven standards with known DNA methylation levels (0–
100%). Each graph plots the average normalized methylation ratio against the expected one, with 
error bars corresponding to each standard’s SD from the three replicates. The R2 values of the 
best-fitted lines (linear or quadratic polynomial) (black lines) are shown in red, while the equations 
used for normalization are shown in Table A2. Blue dotted lines represent the completely linear line 
(R2 = 1). 
 
Figure A3. Linearity curves of methylation quantification for all MethyLight assays corresponding
to the top 22 tDMSs, as generated by using seven standards with known DNA methylation levels
(0–100%). Each graph plots the average normalized methylation ratio against the expected one, with
error bars corresponding to each standard’s SD from the three replicates. The R2 values of the best-fitted
lines (linear or quadratic polynomial) (black lines) are shown in red, while the equations used for
normalization are shown in Table A2. Blue dotted lines represent the completely linear line (R2 = 1).
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Figure A4. DNA methylation values of top tDMSs selected from microarray data in buccal DNA 
(blue) and analyzed with MethyLight qPCR in (a,b) saliva and (c,d) cigarette butts for twin 
individuals A and B; (a,b) tDMSs with <0.1 methylation differences in saliva and cigarette butts but 
with the same direction as in buccal cells (N = 7 and N = 5, respectively), (c) tDMSs with opposite 
direction of methylation differences between sample types (false positives) (N = 9 for saliva and N = 6 
for cigarette butts). The bars correspond to average detected methylation (triplicate analysis), while 
error bars indicate observed standard deviation. 
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